Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice
Open accessThe DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index; 1 of the 21 sources its claims cite were checked for support.
Abstract
The accumulation of beta-amyloid (A beta) plaques and neurofibrillary tangles consisting of hyperphosphorylated tau protein are pathological features of Alzheimer's disease (AD) commonly modeled in mice using known human familial mutations; however, the loss of neurons also found to occur in AD is rarely observed in such models. The mechanism of neuron degeneration remains unclear but is of great interest as it is very likely an important factor for the onset of adverse memory deficits occurring in individuals with AD. The role of A beta in the neuronal degeneration is a matter of controversial debates. In the present study we investigated the impact of extracellular plaque A beta versus intraneuronal A beta on neuronal cell death. The thalamus and the frontal cortex of the APP/PS1KI mouse model were chosen for stereological quantification representing regions with plaques only (thalamus) or plaques as well as intraneuronal A beta (frontal cortex). A loss of neurons was found in the frontal cortex at the age of 6 months coinciding with the decrease of intraneuronal immunoreactivity, suggesting that the neurons with early intraneuronal A beta accumulation were lost. Strikingly, no neuron loss was observed in the thalamus despite the development of abundant plaque pathology with levels comparable to the frontal cortex. This study suggests that plaques have no effect on neuron death whereas accumulation of intraneuronal A beta may be an early transient pathological event leading to neuron loss in AD.
Overview
CoChat Summary
TL;DR
In APP/PS1KI mice, frontal cortex showed transient intraneuronal Aβ accumulation and neuron loss, whereas thalamus had comparable plaque pathology but no intraneuronal Aβ and no neuron loss. The authors conclude that plaques do not affect neuronal survival, while transient intraneuronal Aβ accumulation coincides with neuron death.
Key findings
- Frontal cortex neuron loss was 28% at 6 months and 35% at 12 months in APP/PS1KI mice versus PS1KI controls, with corresponding cortical volume reductions of 25% and 23% at 6 and 12 months.
- Thalamus showed no significant neuron loss at 2, 6, or 12 months despite plaque pathology; Aβ-covered area was 1.5% at 2 months, 8.5% at 6 months, and 13.9% at 12 months, with the increase due to an 11-fold rise in plaque number from 2 to 12 months and no major change in average plaque size.
- Frontal cortex Aβ-covered area was 4.7% at 2 months and 12.1% at 6 months, then remained stable to 12 months; intraneuronal Aβ was prominent at 1.5 and 2 months and decreased at 6 months, while the 2-to-6-month increase in Aβ area was due to a 2.7-fold increase in grain numbers.
- No intraneuronal Aβ was detected in thalamus regardless of age; APP transgene expression was found in frontal cortex neurons but not thalamic neurons.
Methods
- APP/PS1KI mice and PS1KI controls were analyzed; stereology used female mice at 2 months (n = 5), 6 months (n = 6), and 12 months (n = 8). Aβ load quantification used 3, 5, and 4 animals at 2, 6, and 12 months, respectively.
- Design-based stereology (optical fractionator) was performed on cresyl violet-stained frozen sections, counting every tenth section, with frontal cortex quantified from Bregma 3.08–0.26 and thalamus from Bregma −0.94 to −2.54; counting was blinded to genotype.
- Immunohistochemistry used 4G8, an N-terminal Aβ antibody, N1D, N3pE, and G2-10; Aβ load was measured with ImageJ. Stereology data were analyzed by two-way ANOVA with Bonferroni posttests, and Aβ pathology by one-way ANOVA followed by t tests.
Limitations
- The paper states that it cannot completely rule out that thalamic neurons differ from cortical neurons and may be less vulnerable in general.
- The paper states that mutant PS1 may induce toxic effects per se, but because PS1KI littermate controls had unchanged neuron numbers, the authors conclude the PS1-FAD mutations alone had no effect on neuron survival.
- Evident from the text: the findings are correlational in a mouse model, only female mice were analyzed, and the authors note that proving the intraneuronal Aβ hypothesis in human AD tissue is difficult because end-stage pathology may no longer show intraneuronal Aβ immunoreactivity.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 1 Not valid · 6 Not checked · 22 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A loss of neurons was found in the frontal cortex at the age of 6 months coinciding with the decrease of intraneuronal immunoreactivity”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Strikingly, no neuron loss was observed in the thalamus despite the development of abundant plaque pathology with levels comparable to the frontal cortex.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Strikingly, no neuron loss was observed in the thalamus despite the development of abundant plaque pathology with levels comparable to the frontal cortex.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Correspondingly, no change in thalamic volume was found between APP/PS1KI and PS1KI control mice at any age investigated”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“as we have used PS1KI littermates as control mice, which have unchanged neuron numbers during aging in both thalamus and frontal cortex”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
10 more claims
Create a free account to see all 30 claims and to verify the 20 references still open.
- It may state two separate claims as one. 12
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“PS1/APP mutant transgenic mice were shown to have prominent intraneuronal Aβ accumulation associated with neuron cell death [23, 35, 167].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [35]
The cited source says what the claim attributes to it.
In the citing paper
“While the frontal cortex represents an area with both intra- and extracellular Aβ accumulation, no intracellular deposits are present in the thalamus. The amount of extracellular plaque pathology, however, is comparable between both brain regions, pointing to a critical role of transient intraneuronal Aβ accumulations with regard to neurodegeneration [53].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Results · p. 6
“an increased number of deposits ( c ) as no change in average deposit size was detected ( e ).”
§ Results · p. 6
“the average size decreased ( c ) and the number of deposits tended to increase ( e , P = 0.075).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Results · p. 6
“no change in thalamic volume was found between APP/PS1KI and PS1KI control mice at any age investigated (Fig. 5d).”
§ Discussion · p. 7
“otherwise no changes in thalamic volume were observed ( e ).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Results · p. 3
“increases further to 13.9% in the thalamus (Fig. 4a, b).”
§ Discussion · p. 7
“extracellular plaques covering 13.1% of this region at the age of 12 months.”
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“A further pathological determinant is loss of neurons, which occurs predominantly in the cortex, the hippocampal formation, and the nucleus basalis of Meynert [2, 3, 18, 22, 25].”
BackgroundThe Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 13,437
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172 · cited 1×
“A further pathological determinant is loss of neurons, which occurs predominantly in the cortex, the hippocampal formation, and the nucleus basalis of Meynert [2, 3, 18, 22, 25].”
BackgroundWest, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994 · cited 1×
“Estimation of the total number of neurons in hemispheres was performed according to the principle of stereology [17, 21, 24].”
MethodAlzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736 · cited 1×
“A further pathological determinant is loss of neurons, which occurs predominantly in the cortex, the hippocampal formation, and the nucleus basalis of Meynert [2, 3, 18, 22, 25].”
BackgroundDifferences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease
West, M. J., Coleman, P. D., Flood, D. G., & Troncoso, J. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92338-8 · Cited by 1,267 · cited 2×
“The APP/PS1KI mice represent a valuable model system, as they develop an extensive neuron loss in the CA1 region of the hippocampal formation [4], a characteristic also found in AD patients [22], which is preceded by strong intraneuronal Ab accumulation, as well as a severe motor pathology, axonal degeneration marked…”
BackgroundIntraneuronal Aβ42 Accumulation in Human Brain
Gouras, G. K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J. P., Haroutunian, V., Buxbaum, J. D., Xu, H., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64700-1 · Cited by 991 · cited 2×
“In addition, another study claims that intraneuronal Ab42 in human AD is only detectable in patients with low Braak stages and short disease duration and that the intraneuronal immunoreactivity is lost in patients with more progressive AD [11].”
BackgroundDesign-based stereology in neuroscience
Schmitz, C., & Hof, P. R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.050 · Cited by 681 · cited 1×
“Estimation of the total number of neurons in hemispheres was performed according to the principle of stereology [17, 21, 24].”
MethodFibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches
Tsai, J., Grutzendler, J., Duff, K., & Gan, W.-B. (2004) · Nature Neuroscience · doi:10.1038/nn1335 · Cited by 561 · cited 1×
“Plaques are known to cause disturbances in the fiber network developing dystrophic swellings of surrounding fibers and mediate loss of dendritic spines [1, 7, 19, 29].”
BackgroundCasas, C., Sergeant, N., Itier, J.-M., Blanchard, V., Wirths, O., van der Kolk, N., Vingtdeux, V., van de Steeg, E., Ret, G., Canton, T., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63388-3 · Cited by 400 · cited 2×
“The APP/PS1KI mice represent a valuable model system, as they develop an extensive neuron loss in the CA1 region of the hippocampal formation [4], a characteristic also found in AD patients [22], which is preceded by strong intraneuronal Ab accumulation, as well as a severe motor pathology, axonal degeneration marked…”
BackgroundMethodSelf-citation
Cited by
Classification and basic pathology of Alzheimer disease
Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031
“They concluded that the neuronal loss was related to iAb [66].”
BackgroundJawhar, S., Trawicka, A., Jenneckens, C., Bayer, T. A., & Wirths, O. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.027 · Cited by 623
“…striatum, representing regions where only extracellular plaques are detectable, no neuron loss could be demonstrated (Breyhan et al., 2009; Casas et al., 2004; Christensen et al., 2008; Christensen et al., 2010), arguing against a significant role of extracellular plaques in terms of A toxicity.”
BackgroundMethodInfluentialSelf-citationYang, D.-S., Stavrides, P., Mohan, P. S., Kaushik, S., Kumar, A., Ohno, M., Schmidt, S. D., Wesson, D., Bandyopadhyay, U., Jiang, Y., et al. (2011) · Brain · doi:10.1093/brain/awq341 · Cited by 429
“…accumulation of intraneuronal Ab in Alzheimer’s disease is an early event that precedes extracellular Ab deposition (Takahashi et al., 2002; Cataldo et al., 2004a; Billings et al., 2005) and is strongly implicated in the mechanism of neurodegeneration in these models (Christensen et al., 2008).”
BackgroundEimer, W. A., & Vassar, R. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-2 · Cited by 425
“The early appearance of intraneuronal Aβ42 and its correlation with neuron loss in 5XFAD mice is also shared with the APPPS1KI transgenic mouse model [11,33,37,38].”
BackgroundIntraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease
Gouras, G. K., Tampellini, D., Takahashi, R. H., & Capetillo-Zarate, E. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0679-9 · Cited by 372
“Additionally, PS1/APP mutant transgenic mice were shown to have prominent intraneuronal Ab accumulation associated with neuron cell death [23, 35, 167].”
Truncated and modified amyloid-beta species
Kummer, M. P., & Heneka, M. T. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt258 · Cited by 341
“pE-Aβ has been detected in a variety of AD mouse models, yet the time of first appearance during pathology varies strongly between different mouse models – ranging from 2 months in the APP/PS1KI model [72], to 16 months in the Tg2576 model [73], to 15 months in the APP23 model [20].”
BackgroundBayer (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00008 · Cited by 252
“…APP T714I mice (Van Broeck et al., 2008), in APP SL PS1KI M233T, L235P mice (Casas et al., 2004) in which it was recently shown to correlate with neuron loss (Christensen et al., 2008a,b; Breyhan et al., 2009), as well as in TBA2 mice expressing pyroglutamate modifi ed Aβ3-42 (Wirths et al., 2009).”
Pyroglutamate Amyloid-β (Aβ): A Hatchet Man in Alzheimer Disease
Jawhar, S., Wirths, O., & Bayer, T. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.288308 · Cited by 218
Self-citationThe Role of the Tripartite Glutamatergic Synapse in the Pathophysiology of Alzheimer’s Disease
Rudy, C. C., Hunsberger, H. C., Weitzner, D. S., & Reed, M. N. (2015) · Aging and disease · doi:10.14336/ad.2014.0423 · Cited by 171
“The Journal of neuroscience, 25: 11061-11070 [120] Christensen DZ, Kraus SL, Flohr A, Cotel MC, Wirths O, Bayer TA (2008).”
BackgroundBouter, Y., Dietrich, K., Wittnam, J. L., Rezaei-Ghaleh, N., Pillot, T., Papot-Couturier, S., Lefebvre, T., Sprenger, F., Wirths, O., Zweckstetter, M., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1129-2 · Cited by 175
“For example, APP/PS1KI mice exhibit neuron loss in the CA1 region of the hippocampus [4, 7], the frontal cortex [8], and in distinct cholinergic nuclei [9].”
BackgroundSelf-citationWirths, O., Breyhan, H., Cynis, H., Schilling, S., Demuth, H.-U., & Bayer, T. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0557-5 · Cited by 174
“In addition, only a fraction of Purkinje cells showed abundant levels of intracellular Ab3(pE) accumulation leading to the assumption that only those are prone for degeneration (Fig. 4). We have previously shown that at 6 months, the APP/PS1KI mice exhibit a neuron loss in CA1 of the hippocampus [4, 8], the frontal co…”
BackgroundSelf-citationHüttenrauch, M., Ogorek, I., Klafki, H., Otto, M., Stadelmann, C., Weggen, S., Wiltfang, J., & Wirths, O. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0612-3 · Cited by 166
“hippocampal and cortical neuron loss [3, 6].”
Self-citationPeric, A., & Annaert, W. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1379-7 · Cited by 161
“In APP(SL)/PS1KI mice, in turn, internal pile up of Aβ, rather than its external deposition in APs, associates with neuronal loss [23].”
BackgroundIntraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody
Youmans, K. L., Tai, L. M., Kanekiyo, T., Stine Jr, W. B., Michon, S.-C., Nwabuisi-Heath, E., Manelli, A. M., Fu, Y., Riordan, S., Eimer, W. A., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-8 · Cited by 164
“[17,19,22,24].”
BackgroundThe Toxicity of Amyloid ß Oligomers
Zhao, L. N., Long, H. W., Mu, Y., & Chew, L. Y. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13067303 · Cited by 152
“early synaptic deficits, cholinergic neuron loss, and hippocampus atrophy [66–69].”
BackgroundProteinopathies, a core concept for understanding and ultimately treating degenerative disorders?
Bayer, T. A. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.03.007 · Cited by 140
Self-citationRichard, B. C., Kurdakova, A., Baches, S., Bayer, T. A., Weggen, S., & Wirths, O. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-143120 · Cited by 142
Self-citationVenkataramani, V., Rossner, C., Iffland, L., Schweyer, S., Tamboli, I. Y., Walter, J., Wirths, O., & Bayer, T. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.057836 · Cited by 133
Accumulation of intraneuronal Aβ correlates with ApoE4 genotype
Christensen, D. Z., Schneider-Axmann, T., Lucassen, P. J., Bayer, T. A., & Wirths, O. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0666-1 · Cited by 120
“During the last years, it has been convincingly reported in several mouse models including APPSDLPS1M146L [69], APPSLPS1M146L [70], Tg2576 [60], 3xTg-AD [48], 5xFAD [47], APPArc [33, 40], APPT714I mice [63], and in APPSLPS1KIM233T,L235P mice [10] in which it was recently shown to correlate with neuron loss [8, 12, 14…”
BackgroundSelf-citationNeuron Loss in Transgenic Mouse Models of Alzheimer's Disease
Wirths, O., & Bayer, T. A. (2010) · International Journal of Alzheimer's Disease · doi:10.4061/2010/723782 · Cited by 111
“No neuron loss could be observed in the thalamus where on extracellular Aβ plaques, however, in a comparable amount as in the cortex were present [32].”
BackgroundSelf-citationInsights into Alzheimer disease pathogenesis from studies in transgenic animal models
Schaeffer, E. L., Figueiró, M., & Gattaz, W. F. (2011) · Clinics · doi:10.1590/s1807-59322011001300006 · Cited by 114
“cortical neurons starting at the age of 6 months which correlated with the transient intraneuronal Ab accumulation in contrast to extracellular Ab plaque pathology.(74) At 10 months of age, an extensive neuronal loss (.”
BackgroundFaure, A., Verret, L., Bozon, B., El Tannir El Tayara, N., Ly, M., Kober, F., Dhenain, M., Rampon, C., & Delatour, B. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.03.009 · Cited by 112
“In particular, intracellular A is ostly detected in brain regions that show subsequent neuonal loss (Christensen et al., 2008a; Oakley et al., 2006). bnormally up-regulated proteins involved in apoptosis and ell survival have recently been identified in APPxPS1-Ki ice (Damjanac et al., 2007; Page…”
BackgroundAn Integrated View on Vascular Dysfunction in Alzheimer’s Disease
Klohs, J. (2019) · Neurodegenerative Diseases · doi:10.1159/000505625 · Cited by 111
Morawski, M., Schilling, S., Kreuzberger, M., Waniek, A., Jäger, C., Koch, B., Cynis, H., Kehlen, A., Arendt, T., Hartlage-Rübsamen, M., et al. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131535 · Cited by 109
Autophagy–lysosomal-associated neuronal death in neurodegenerative disease
Nixon, R. A. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02799-7 · Cited by 133
Smith, A. J., Duan, T., & Verkman, A. S. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0728-0 · Cited by 99
Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer’s disease cases
Wirths, O., Bethge, T., Marcello, A., Harmeier, A., Jawhar, S., Lucassen, P. J., Multhaup, G., Brody, D. L., Esparza, T., Ingelsson, M., et al. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-009-0314-x · Cited by 106
Self-citationAlexandru, A., Jagla, W., Graubner, S., Becker, A., Bäuscher, C., Kohlmann, S., Sedlmeier, R., Raber, K. A., Cynis, H., Rönicke, R., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1794-11.2011 · Cited by 102
“A neurotoxicity in these mice (Christensen et al., 2008; Breyhan et al., 2009; Wirths et al., 2010), and the development of novel imaging systems has further supported the role of pE3–”
BackgroundKumar, S., Wirths, O., Theil, S., Gerth, J., Bayer, T. A., & Walter, J. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1107-8 · Cited by 99
“The presence of intraneuronal Ab accumulations has been reported in several mouse models and human AD brain [6, 12, 35, 49].”
Self-citationP‐glycoprotein: a role in the export of amyloid‐β in Alzheimer's disease?
Chai, A. B., Leung, G. K. F., Callaghan, R., & Gelissen, I. C. (2020) · The FEBS Journal · doi:10.1111/febs.15148 · Cited by 96
Côtel, M.-C., Jawhar, S., Christensen, D. Z., Bayer, T. A., & Wirths, O. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.02.012 · Cited by 104
“In the present mouse model, extracellular plaques are already present to a certain extent in 2-month-old APP/ PS1KI mice at the starting point of the enrichment (Christensen et al., 2008).”
Self-citationIntraneuronal Aβ accumulation and neurodegeneration: Lessons from transgenic models
Wirths, O., & Bayer, T. A. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.02.001 · Cited by 107
Self-citationAPP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy
Breyhan, H., Wirths, O., Duan, K., Marcello, A., Rettig, J., & Bayer, T. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0539-7 · Cited by 87
“Previously, we have reported that transient intraneuronal Abeta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice [ 5 ].”
BackgroundSelf-citationAgostinho, P., Pliássova, A., Oliveira, C. R., & Cunha, R. A. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142730 · Cited by 85
“This is supported by the presence of significant intracellular amounts of A!, whose accumulation augments with age, and seems to be correlated with the disruption of neurites cytoarchitecture and neuronal loss [108, 109].”
BackgroundSaul, A., Sprenger, F., Bayer, T. A., & Wirths, O. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.003 · Cited by 88
Self-citationAge-associated cerebral atrophy in mouse lemur primates
Kraska, A., Dorieux, O., Picq, J.-L., Petit, F., Bourrin, E., Chenu, E., Volk, A., Perret, M., Hantraye, P., Mestre-Frances, N., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.05.018 · Cited by 82
Wittnam, J. L., Portelius, E., Zetterberg, H., Gustavsson, M. K., Schilling, S., Koch, B., Demuth, H.-U., Blennow, K., Wirths, O., & Bayer, T. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.308601 · Cited by 77
Self-citationBouter, Y., Kacprowski, T., Weissmann, R., Dietrich, K., Borgers, H., Brauß, A., Sperling, C., Wirths, O., Albrecht, M., Jensen, L. R., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00075 · Cited by 76
Self-citationNeuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models
Wirths, O., & Zampar, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218144 · Cited by 75
“The amount of extracellular plaque pathology, however, is comparable between both brain regions, pointing to a critical role of transient intraneuronal Aβ accumulations with regard to neurodegeneration [53].”
BackgroundSelf-citationOlajide, O. J., Suvanto, M. E., & Chapman, C. A. (2021) · Biology Open · doi:10.1242/bio.056796 · Cited by 80
“More recent findings have found that soluble oligomeric Aβ, rather than insoluble amyloid plaques, have a more potent role in initiating cell death in AD (Barghorn et al., 2005; Christensen et al., 2008; Demuro et al., 2010; Gong et al., 2003; Lacor et al., 2007).”
BackgroundBouter, Y., López‐Noguerola, J. S., Tucholla, P., Crespi, G. A. N., Parker, M. W., Wiltfang, J., Miles, L. A., & Bayer, T. A. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1489-x · Cited by 79
Self-citationHip14l-deficient mice develop neuropathological and behavioural features of Huntington disease
Sutton, L. M., Sanders, S. S., Butland, S. L., Singaraja, R. R., Franciosi, S., Southwell, A. L., Doty, C. N., Schmidt, M. E., Mui, K. K. N., Kovalik, V., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds441 · Cited by 76
Geldenhuys, W. J., & Van der Schyf, C. J. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.51 · Cited by 73
Linking pathways in the developing and aging brain with neurodegeneration
Kovács, G. G., Adle‐Biassette, H., Milenković, I., Cipriani, S., van Scheppingen, J., & Aronica, E. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.045 · Cited by 75
Monoaminergic System Modulation in Depression and Alzheimer’s Disease: A New Standpoint?
Morgese, M. G., & Trabace, L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00483 · Cited by 75
Omtri, R. S., Davidson, M. W., Arumugam, B., Poduslo, J. F., & Kandimalla, K. K. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200530q · Cited by 69
Hashimoto, M., Bogdanovic, N., Volkmann, I., Aoki, M., Winblad, B., & Tjernberg, L. O. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0661-6 · Cited by 69
“Furthermore, a study by Christensen et al. [ 9 ] clearly indicated that a transient intraneuronal Ab accumulation coincides with neuronal loss in the frontal cortex of APP/PS1knock-in mice.”
BackgroundHartlage-Rübsamen, M., Morawski, M., Waniek, A., Jäger, C., Zeitschel, U., Koch, B., Cynis, H., Schilling, S., Schliebs, R., Demuth, H.-U., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0806-2 · Cited by 64
“However, at the high dilution used here (1:5,000), the antibody then detects only Ab [ 11 ].”
BackgroundEarly Onset Alzheimer’s Disease and Oxidative Stress
Meraz-Ríos, M. A., Franco-Bocanegra, D., Toral Rios, D., & Campos-Peña, V. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/375968 · Cited by 63
Spuch, C., Antequera, D., Fernández‐Bachiller, M. I., Rodríguez-Franco, M. I., & Carro, E. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9121-2 · Cited by 69
“Significant neuronal loss, a common pathological feature of AD patients, was found in the hippocampus of these animals, agreeing with previous studies (Christensen et al. 2008).”
ResultHeggland, I., Storkaas, I. S., Soligard, H., Kobro‐Flatmoen, A., & Witter, M. P. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12876 · Cited by 60
“, 1997), and animal studies that indicate that oligomeric Ab, rather than plaque load, play a role in neuronal damage (Casas et al., 2004; Christensen et al., 2008; DaRocha-Souto et al., 2011).”
BackgroundAntonios, G., Saiepour, N., Bouter, Y., Richard, B. C., Paetau, A., Verkkoniemi-Ahola, A., Lannfelt, L., Ingelsson, M., Kovacs, G. G., Pillot, T., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-56 · Cited by 53
“Such transient appearance of intraneuronal accumulation of Aβ peptides in young APP transgenic has already been described earlier [41].”
BackgroundSelf-citationAltered neurogenesis in mouse models of Alzheimer disease
Wirths, O. (2017) · Neurogenesis · doi:10.1080/23262133.2017.1327002 · Cited by 51
“No such neuron loss could be detected in the thalamus, a brain region also harbouring massive extracellular amyloid pathology, however, in the absence of APP expression and intraneuronal Ab accumulation.(33) To assess whether cognitive stimulation and enhanced physical activity might have an influence on behavioral al…”
MethodSelf-citationJakobsen, J. E., Johansen, M. G., Schmidt, M., Liu, Y., Li, R., Callesen, H., Melnikova, M., Habekost, M., Matrone, C., Bouter, Y., et al. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160408 · Cited by 46
“…the M146L and L286V mutations (5XFAD mouse) [40], or A (cid:2) PP with Swedish and London mutations and PSEN1 knock-in mutations M233T and L235P [41–43], and a triple transgenic model carrying A (cid:2) PP with Swedish mutation, PSEN1 with the M146V mutation, and tau with the P301L mutation [44].”
Self-citationMemantine prevents memory consolidation failure induced by soluble beta amyloid in rats
Tucci, P., Mhillaj, E., Morgese, M. G., Colaianna, M., Zotti, M., Schiavone, S., Cicerale, M., Trezza, V., Campolongo, P., Cuomo, V., et al. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00332 · Cited by 54
“…impairment is poorly correlated with counts of “senile plaques” in cerebral gray matter either in patients (Blennow et al., 1996; Berg et al., 1998; Giannakopoulos et al., 2003, 2009) or in animal models (Puoliväli et al., 2002; Christensen et al., 2008; Watanabe et al., 2009; Zhang et al., 2012).”
BackgroundChristensen, D. Z., Bayer, T. A., & Wirths, O. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.014 · Cited by 47
Self-citationThe continuum between neurodegeneration, brain plasticity, and movement: a critical appraisal
Schirinzi, T., Canevelli, M., Suppa, A., Bologna, M., & Marsili, L. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0011 · Cited by 52
Ohta, M., Higashi, Y., Yawata, T., Kitahara, M., Nobumoto, A., Ishida, E., Tsuda, M., Fujimoto, Y., & Shimizu, K. (2012) · Brain Research · doi:10.1016/j.brainres.2012.09.011 · Cited by 51
No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's disease
Hillmann, A., Hahn, S., Schilling, S., Hoffmann, T., Demuth, H., Bulic, B., Schneider-Axmann, T., Bayer, T. A., Weggen, S., & Wirths, O. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.006 · Cited by 53
“Plaque load was quanti- ed in the cortex and the hippocampus as described earlier Christensen et al., 2008) (Fig.”
MethodSelf-citationYang, W., Ma, K., Chen, X. L., Shi, L., Bu, G., Hu, X. D., Han, H., Liu, Y., & Qian, Y. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.08.013 · Cited by 49
Caneus, J., Akanda, N., Rumsey, J. W., Guo, X., Jackson, M., Long, C. J., Sommerhage, F., Georgieva, S., Kanaan, N. M., Morgan, D., et al. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12029 · Cited by 33
The Inside-Out Amyloid Hypothesis and Synapse Pathology in Alzheimer's Disease
Gouras, G. K., Willén, K., & Faideau, M. (2014) · Neurodegenerative Diseases · doi:10.1159/000354776 · Cited by 42
Mohamed, A., Saavedra, L., Di Pardo, A., Sipione, S., & Posse de Chaves, E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0630-12.2012 · Cited by 41
“-Amyloid Inhibits Protein Prenylation and Induces”
BackgroundBrainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease
Overk, C. R., Kelley, C. M., & Mufson, E. J. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.004 · Cited by 42
“…and progression of Aβ plaques in the cerebral and limbic cortices (Borchelt et al. 1997; Gordon et al. 2002; Holcomb et al. 1998; Hsiao et al. 1996; Jaffar et al. 2001; Wengenack et al. 2000), whereas only a few studies have reported brainstem Aβ plaque pathology (Christensen et al. 2008a).”
BackgroundLemmens, M. A. M., Sierksma, A. S. R., Rutten, B. P. F., Dennissen, F., Steinbusch, H. W. M., Lucassen, P. J., & Schmitz, C. (2011) · Brain Structure and Function · doi:10.1007/s00429-011-0305-1 · Cited by 37
Morawski, M., Hartlage-Rübsamen, M., Jäger, C., Waniek, A., Schilling, S., Schwab, C., McGeer, P. L., Arendt, T., Demuth, H.-U., & Roßner, S. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0685-y · Cited by 36
“Such a phenomenon was recently demonstrated in APP/PS1 knock-in mice with neocortical and hippocampal, but not thalamical, transgene expression [ 8 ].”
BackgroundHedberg, M. M., Clos, M. V., Ratia, M., Gonzalez, D., Lithner, C. U., Camps, P., Muñoz‐Torrero, D., Badía, A., Giménez‐Llort, L., & Nordberg, A. K. (2010) · Neurodegenerative Diseases · doi:10.1159/000287954 · Cited by 41
“and a recent study reported that transient intraneuronal Aβ, rather than extracellular Aβ plaques, correlated with neuronal loss in APP/PS1KI mice [”
BackgroundBengtsson, S. K. S., Johansson, M., Bäckström, T. C., & Wang, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120268 · Cited by 36
Synaptic Alterations in Mouse Models for Alzheimer Disease—A Special Focus on N-Truncated Abeta 4-42
Dietrich, K., Bouter, Y., Müller, M., & Bayer, T. A. (2018) · Molecules · doi:10.3390/molecules23040718 · Cited by 31
Self-citationYang, W., Ma, K., Qian, Y., Zhang, J.-S., Feng, G.-F., Shi, L., Zhang, Z., & Liu, Z. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.04.013 · Cited by 30
Intercellular communication in the brain through a dendritic nanotubular network
Chang, M., Krüssel, S., Parajuli, L. K., Kim, J., Lee, D., Merodio, A., Kwon, J., Okabe, S., & Kwon, H. (2025) · Science · doi:10.1126/science.adr7403 · Cited by 43
Alterations and interactions of subcortical modulatory systems in Alzheimer's disease
Leko, M. B., Hof, P. R., & Šimić, G. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2020.07.016 · Cited by 32
Chen, Y., Wang, Y., Qin, Q., Zhang, Y., Xie, L., Xiao, J., Cao, Y., Su, Z., & Chen, Y. (2022) · Food & Function · doi:10.1039/d1fo02965g · Cited by 33
Christensen, D. Z., Hüttenrauch, M., Mitkovski, M., Pradier, L., & Wirths, O. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00139 · Cited by 34
“The following antibodies were applied: 4G8 (Covance, 1:10.000) (Christensen et al., 2008), OC (generous gift of Glabe and Kayed, 1:1000) (Kayed et al., 2007) and Aβ[N] (IBL, 1:500) (Christensen et al., 2010) against Aβ, 22C11 (Millipore, 1:1000) and 23850 (generous gift of G. Multhaup, 1:500)…”
BackgroundInfluentialSelf-citationHu, Y.-B., Zou, Y., Huang, Y. M., Zhang, Y., Lourenco, G. F., Chen, S., Halliday, G. M., Wang, G., & Ren, R. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00253 · Cited by 33
“The buildup of internal Aβ rather than its external deposition is associated with neuronal loss in APP/PS1 knock-in mice suggesting externalization of cellular Aβ is protective (Christensen et al., 2008).”
BackgroundGuzmán, E. A., Bouter, Y., Richard, B. C., Lannfelt, L., Ingelsson, M., Paetau, A. E., Verkkoniemi‐Ahola, A., Wirths, O., & Bayer, T. A. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-13 · Cited by 34
“During the last years, intraneuronal accumulation has been reported in several mouse models including APPSDLPS1M146L [41], APPSLPS1M146L [42], Tg2576 [43], 3xTg-AD [19], APPArc [44,45], 5XFAD [21], APPT714I [46], APPSL/PS1M146L [47], APP/PS1KI [20,48,49], TBA2 mice expressing pyroglutamate modified Aβ3–42 [50] and in…”
BackgroundSelf-citationAβPP Accumulation and/or Intraneuronal Amyloid-β Accumulation? The 3xTg-AD Mouse Model Revisited
Wirths, O., Dins, A., & Bayer, T. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111529 · Cited by 26
“All of these brain regions show an age-dependent neuron loss between 25 and 50%, whereas brain regions with a comparable plaque load lacking intraneuronal A accumulation never develop neuron loss [24, 25].”
BackgroundSelf-citationVolloch, V., & Rits‐Volloch, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512246 · Cited by 31
Nacre Extract from Pearl Oyster Shell Prevents D-Galactose-Induced Brain and Skin Aging
Yamamoto, H., Shimomura, N., Oura, K., & Hasegawa, Y. (2023) · Marine Biotechnology · doi:10.1007/s10126-022-10192-2 · Cited by 28
The Amyloid Cascade Hypothesis 2.0: Generalization of the Concept
Volloch, V., & Rits‐Volloch, S. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220079 · Cited by 22
“There is a good correlation between levels of iA and the occurrence of AD markers [15, 31].”
BackgroundGiuliani, A., Beggiato, S., Baldassarro, V. A., Mangano, C., Giardino, L., Imbimbo, B. P., Antonelli, T., Calzà, L., & Ferraro, L. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12136 · Cited by 23
Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer’s Disease
Weissmann, R., Hüttenrauch, M., Kacprowski, T., Bouter, Y., Pradier, L., Bayer, T. A., Kuss, A. W., & Wirths, O. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150745 · Cited by 21
Self-citationSaul, A., Lashley, T., Révész, T., Holton, J. L., Ghiso, J. A., Coomaraswamy, J., & Wirths, O. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.014 · Cited by 23
Self-citationAshabi, G., Ahmadiani, A., Abdi, A., Abraki, S. B., & Khodagholi, F. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.05.005 · Cited by 21
Barrier, L., Fauconneau, B., Noël, A., & Ingrand, S. S. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2011/920958 · Cited by 21
“An important difference between these single APP mouse lines and the APPSL/PS1Ki model is that the latter develops an early and massive neuronal loss which correlates with strong accumulation of intracellular Aβ42, Aβ aggregates, and Aβ42 oligomers [28, 36].”
BackgroundLópez‐Noguerola, J. S., Gießen, N. M.-E., Ueberück, M., Meißner, J. N., Pelgrim, C. E., Adams, J., Wirths, O., Bouter, Y., & Bayer, T. A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00064 · Cited by 23
“For the stereological analysis, mice were anesthetized and transcardially perfused with 4% paraformaldehyde as previously described (Christensen et al., 2008).”
MethodSelf-citationEndosomal trafficking and related genetic underpinnings as a hub in Alzheimer's disease
Limone, A., Veneruso, I., D’Argenio, V., & Sarnataro, D. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30864 · Cited by 18
“…of Aβ peptides is associated to synaptic function impairment, cognitive defects, and neuronal loss; moreover, these alterations may anticipate the external deposition of the amyloidogenic plaques (Billings et al., 2005; Christensen et al., 2008; Knobloch et al., 2007; Tomiyama et al., 2010).”
BackgroundMeißner, J. N., Bouter, Y., & Bayer, T. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142868 · Cited by 16
Self-citationYeapuri, P., Machhi, J., Foster, E. G., Kadry, R., Bhattarai, S., Lu, Y., Sil, S., Sapkota, R., Srivastava, S., Kumar, M., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70084 · Cited by 16
N-Terminal Truncated Aβ4-42 Is a Substrate for Neprilysin Degradation in vitro and in vivo
Hornung, K. A., Zampar, S., Engel, N., Klafki, H., Liepold, T., Bayer, T. A., Wiltfang, J., Jahn, O., & Wirths, O. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181134 · Cited by 16
Self-citationVolloch, V., & Rits‐Volloch, S. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220031 · Cited by 16
“Moreover, these studies suggested that iA accumulation, rather than extracellular plaque pathology, correlates with neuronal loss [19].”
BackgroundQuantitative Characterization of Metastability and Heterogeneity of Amyloid Aggregates
Sil, T. B., Sahoo, B., Bera, S. C., & Garai, K. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2017.12.023 · Cited by 8
Ma, K., Lv, J., Hu, X. D., Shi, L., Chang, K.-W., Chen, X., Qian, Y., Yang, W., & Qu, Q. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.04.019 · Cited by 16
Role of hippocalcin in mediating Aβ toxicity
Lim, Y.-A., Giese, M., Shepherd, C. E., Halliday, G. M., Kobayashi, M., Takamatsu, K., Staufenbiel, M., Eckert, A., & Götz, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.04.007 · Cited by 16
Fiber Tracts Anomalies in APPxPS1 Transgenic Mice Modeling Alzheimer's Disease
Chen, H., Epelbaum, S., & Delatour, B. (2011) · Journal of Aging Research · doi:10.4061/2011/281274 · Cited by 21
Song, H., Chang, Y. J., Moon, M., Park, S. K., Tran, P., Hoang, V.-H., Lee, J., & Mook‐Jung, I. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141356 · Cited by 14
Volloch, V., & Rits‐Volloch, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417586 · Cited by 13
Loss of lysosomal acid lipase contributes to Alzheimer's disease pathology and cognitive decline
Barnett, A. M., McNair, E. M., Dawkins, L., Zou, J., Nikolova, V. D., Moy, S. S., Sutherland, G. T., Stevens, J., Colie, M., Katemboh, K., et al. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70486 · Cited by 12
Leko, M. B., Perković, M. N., Španić, E., Štrac, D. Š., Pleić, N., Vogrinc, Ž., Gunjača, I., Bežovan, D., Erjavec, G. N., Klepac, N., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10123118 · Cited by 11
“Activation of 5HT4, 5HT6, and 5HT7 receptors in experimental models of AD resulted in a decrease in Aβ content [44–47], while injections of Aβ in the hippocampi of mouse models of AD [48,49] leads to a reduction in 5HT2A receptor expression.”
BackgroundVolloch, V., & Rits‐Volloch, S. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230037 · Cited by 11
Metadata
- Authors
- Christensen, D. Z., Kraus, S. L., Flohr, A., Cotel, M.-C., Wirths, O., & Bayer, T. A.
- Affiliations
- University of Göttingen (DE)
- Corresponding author
- Wirths, Oliver
- Venue
- Acta Neuropathologica
- Published
- 2008-10-31
- Volume
- 116
- Issue
- 6
- Pages
- 647-655
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2012365932
- Cited by
- 126
- References
- 30
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 5 · 2023: 5 · 2022: 7 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 6 · 2017: 1 · 2016: 5 · 2015: 10 · 2014: 11 · 2013: 8 · 2012: 14
- FWCI
- 7.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- Funders
- European Commission (MEST-CT-2005-020013)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- neuronal loss, neuronal cell death, Alzheimer's disease, frontal cortex, thalamus, amyloid plaques, tau hyperphosphorylation, stereology
- MeSH terms
- Age Factors, Alzheimer Disease, Analysis of Variance, Animals, Frontal Lobe, Humans, Immunohistochemistry, Mice, Transgenic, Nerve Degeneration, Neurons, Thalamus, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Paraffin Embedding, Cell Death, Extracellular Fluid, Mice, Presenilin-1, Gene Knock-In Techniques, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.